Hoth Therapeutics Inc expected to post a loss of 34 cents a share - Earnings Preview

Rocket One

02/04/2025 21:02

Hoth Therapeutics Inc HOTH.OQ HOTH.O is expected to report results on May 12 (estimated) for the period ending March 31 2025

​LSEG's mean analyst estimate for Hoth Therapeutics Inc is for a loss of 34 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts had fallen by about 21.3% in the last three months. ​

Wall Street's median 12-month price target for Hoth Therapeutics Inc is $4.50​, above​ its last closing price of $0.97. ​​​

This summary was machine generated April 2 at 20:02 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)